Viking Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 175,140,000.0 | 170,595.8 | 91,900.5 | 66,023.0 | 43,363.0 | 85,299.1 | 19,305,096.6 | – | – | – | – | 4,270.9 | 19,457.5 | 13,419.0 | 16,102.4 | – | – | – | – | – | – | – | |
| 2.6 | 3.0 | 4.4 | 4.0 | 23.4 | 9.1 | 2.7 | 3.6 | 3.5 | 1.8 | 2.4 | 2.1 | 1.8 | 2.1 | 1.3 | 2.0 | 1.7 | 1.7 | 2.0 | 2.1 | 2.3 | 1.8 | 1.3 | 1.4 | 1.4 | 5.0 | 9.8 | 4.2 | 3.0 | 5.3 | 9.1 | 6.4 | 7.7 | 5.1 | 3.2 | 3.7 | 4.1 | 6.3 | 7.5 | 11.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 168,996,505.6 | 167,445.4 | 89,815.7 | 61,106.9 | 41,065.6 | 79,193.8 | 16,584,629.4 | – | – | – | – | 4,144.3 | 19,009.7 | 13,319.0 | 15,988.1 | – | – | – | – | – | – | – | |
| -44.8% | -46.3% | -34.7% | -47.5% | -25.4% | -12.0% | -8.4% | -3.6% | -1.9% | -3.4% | -2.3% | -3.0% | -3.2% | -4.3% | -7.6% | -5.0% | -6.7% | -5.3% | -6.0% | -7.5% | -8.3% | -13.5% | -20.3% | -21.2% | -24.1% | -6.7% | -4.8% | -3.8% | -6.0% | -3.9% | -0.6% | -1.2% | -1.1% | -2.0% | -4.9% | -5.1% | -7.6% | -6.9% | -9.1% | -9.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7,884.1% | -5,441.6% | -5,524.0% | -5,620.2% | – | – | – | – | – | – | -67.0% | -67.4% | -67.9% | -71.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,707,881,040.9% | -1,857,034.9% | -1,017,953.5% | -1,039,155.4% | -1,077,338.2% | -2,283,155.8% | -584,878,504.7% | – | – | – | – | -23,125.5% | -26,230.0% | -28,595.6% | -30,726.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,628,921,933.1% | -1,811,409.3% | -1,001,965.3% | -1,026,241.1% | -1,065,836.4% | -2,258,143.4% | -576,299,065.4% | – | – | – | – | -19,700.7% | -21,495.4% | -22,189.2% | -22,741.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,053,940,520.4% | -1,281,860.4% | -761,487.7% | -888,065.3% | -882,050.9% | -1,804,254.0% | -465,616,822.4% | – | – | – | – | -16,829.4% | -12,584.2% | -16,501.1% | -17,029.6% | – | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -158.3% | -183.2% | -216.9% | -270.9% | -904.7% | -152.8% | -26.0% | -14.5% | -6.9% | -7.4% | -8.0% | -8.5% | -8.3% | -9.3% | -11.4% | -12.4% | -14.2% | -16.2% | -18.5% | -22.1% | -25.1% | -27.2% | -31.3% | -35.8% | -40.8% | -47.4% | -53.9% | -19.2% | -22.0% | -24.7% | -10.0% | -10.5% | -10.9% | -12.5% | -15.1% | -21.6% | -33.3% | -56.3% | -94.1% | -131.0% | |
| -99.1% | -101.3% | -108.0% | -124.6% | -170.1% | -93.0% | -23.9% | -14.1% | -6.8% | -7.3% | -7.8% | -8.3% | -8.1% | -9.1% | -11.0% | -12.0% | -13.7% | -15.4% | -17.5% | -20.9% | -23.9% | -26.1% | -29.3% | -32.6% | -37.0% | -40.9% | -47.9% | -18.5% | -21.1% | -23.3% | -9.7% | -10.2% | -10.6% | -12.1% | -14.8% | -20.7% | -32.1% | -50.2% | -77.7% | -102.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -0.2 | 0.2 | 2.6 | -0.3 | 0.6 | -5.5 | -33 | -35 | -170 | – | -13 | -19 | -31 | -8.1 | -15 | -18 | -3.5 | -29 | -17 | -8.6 | -11 | -26 | -12 | -16 | -29 | -36 | -18 | -69 | -37 | -55 | -195 | -44 | -50 | -26 | -37 | -33 | -100 | -166 | – | -126 | |
| 62.6% | 55.3% | 49.8% | 46.0% | 18.8% | 60.9% | 92.0% | 97.2% | 98.5% | 98.5% | 98.2% | 97.9% | 97.7% | 97.5% | 96.8% | 96.6% | 96.3% | 95.3% | 94.8% | 94.6% | 94.9% | 95.8% | 93.5% | 91.0% | 90.8% | 86.2% | 88.8% | 96.4% | 96.2% | 94.6% | 96.5% | 97.3% | 97.2% | 96.9% | 97.7% | 96.1% | 96.4% | 89.3% | 82.5% | 78.2% | |
| 0.3 | 0.4 | 0.9 | 0.5 | 1.4 | 0.3 | 0.1 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.85 | -0.74 | -0.73 | -0.74 | -0.73 | -0.69 | -0.42 | -0.39 | -0.34 | -0.31 | -0.33 | -0.34 | -0.33 | -0.36 | -0.42 | -0.45 | -0.50 | -0.54 | -0.59 | -0.64 | -0.69 | -0.72 | -0.74 | -0.77 | -0.81 | -0.90 | -0.92 | -0.75 | -0.81 | -0.86 | -0.91 | -0.88 | -0.89 | -0.99 | -1.14 | -1.53 | -2.11 | -3.15 | -4.09 | -4.61 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.54 | 0.40 | 0.34 | 0.27 | 0.08 | 0.45 | 1.60 | 2.66 | 4.93 | 4.17 | 4.11 | 4.01 | 3.94 | 3.85 | 3.71 | 3.61 | 3.49 | 3.35 | 3.17 | 2.89 | 2.73 | 2.63 | 2.35 | 2.15 | 1.98 | 1.90 | 1.71 | 3.90 | 3.69 | 3.48 | 9.03 | 8.34 | 8.22 | 7.91 | 7.56 | 7.09 | 6.35 | 5.61 | 4.34 | 3.52 | |
| -0.63 | -0.56 | -0.52 | -0.52 | -0.48 | -0.49 | -0.37 | -0.34 | -0.33 | -0.26 | -0.23 | -0.25 | -0.22 | -0.34 | -0.36 | -0.36 | -0.39 | -0.30 | -0.38 | -0.45 | -0.52 | -0.62 | -0.61 | -0.61 | -0.65 | -0.63 | -0.80 | -0.61 | -0.67 | -0.73 | -0.53 | -0.65 | -0.67 | -0.79 | -1.20 | -1.36 | -2.00 | -2.44 | -2.94 | -3.61 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.